ロード中...
Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle
Policy makers face challenges with the number of drugs for rare indications and rapidly rising costs. In facing these challenges, decision-makers see real-world evidence (RWE) as an opportunity. Health Canada and the Canadian Agency for Drugs and Technologies in Health (CADTH) recently announced the...
保存先:
| 出版年: | Healthc Policy |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Longwoods Publishing
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294449/ https://ncbi.nlm.nih.gov/pubmed/32538348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12927/hcpol.2020.26225 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|